Given that complex IV deficient neurons demonstrate ARMD, we tested whether transport of mitochondria from complex IV deficient neuronal cell bodies to the axon can be enhanced by targeting mitochondrial over-expression of Miro1, PGC1α and pioglitazone treatment. This evidence concerns the gene PPARGC1A and age-related macular degeneration.